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Background: Enteric fever caused by Salmonella enterica serovar Typhi has not been adequately explored in Jordan.  
Methodology: In this study we investigated antibiotic resistance patterns and resistance determinants coupled with fingerprint 
methods of forty-eight isolates of S. Typhi obtained from 113 patients with suspected enteric fever admitted at six governmental 
hospitals in different directorates in Jordan. Twenty-four isolates were from an outbreak of typhoid fever that occurred between 
October 2004 and January 2005, and another twenty-four were from sporadic cases from 2005.  
Results: All isolates of S. Typhi were resistant to streptomycin. A multidrug resistant (MDR) pattern of ampicillin, 
chloramphenicol, co-trimoxazole with tetracycline and streptomycin (R-type ACCoTS) was found in 58% of the epidemic strains 
causing the outbreak and in 98% of the strains from sporadic cases. MDR isolates harbored a single IncHI1 plasmid containing 
a class 1 integron (dfrA7). Plasmid conjugation studies demonstrated a genetic transfer of resistance (ACCoT). S. Typhi isolates 
were all sensitive to fluoroquinolones and cefotaxime, the alternative drugs recommended for treatment of typhoid fever. The 
genomic analysis using PFGE showed: a) the outbreak was caused by an introduced circulating clone with/without an MDR 
plasmid, and b) isolates from the sporadic cases from 2005 are the same MDR clone that persisted and spread in the country.  
Conclusion: The emergence of MDR S. Typhi strains is a majorn important public health issue in Jordan. This study should 
guide selection of effective antibiotic therapy for the treatment of typhoid and monitoring of the spread of MDR of S. Typhi. 
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Introduction 
Typhoid fever caused by Salmonella enterica 
serotype Typhi (S. Typhi) is currently a significant 
cause of morbidity and mortality among children 
and adults in developing countries. In 2004, the 
World Health Organization (WHO) reported an 
annual incidence of 22 million cases with more 
than 216 thousand deaths per year [1]. 
Transmission of the infection occurs mainly 
through consumption of contaminated food or 
water. For this reason, public health measures for 
the prevention of typhoid fever in developing 
countries include access to safe chlorinated water, 
the improvement of food handling practices, and 
provision of hygiene education to the population. 
Chloramphenicol, amoxicillin and trimethoprim-
sulfamethoxazole represent the first-line drugs for 
the treatment of uncomplicated typhoid fever, 
followed by the fluoroquinolones which have been 
widely introduced for their excellent tissue diffusion 
[2]. However, multiple resistance to these 
antibiotics, and more recently to fluoroquinolones, 
has developed among S. Typhi strains [3-6]. Multi-
drug resistant (MDR) isolates have been reported 
as causative agents of numerous outbreaks, 
dramatically reducing the choice of therapy in 
many areas of Africa, Southeast Asia and the 
Indian subcontinent [7-10] where typhoid fever is 
endemic. 
Data, epidemiological studies or reports from 
the Ministry of Health in Jordan concerning typhoid 
fever and other enteric diseases in the country are 
limited. The incidence of infection and outbreaks is 
not well known and probably underestimated as 
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many outbreaks go unnoticed. This is due to the 
difficulty of monitoring and tracing the spread of 
pathogens, as there is often a lack of laboratory 
identification and characterization of the causative 
agents and no well-organized surveillance system 
in place.  
However, despite improving sanitation levels of 
drinking water and sewage disposal, Jordan 
experiences several outbreaks of enteric 
pathogens every year, implicating contaminated 
water or food as potential sources of infections. 
Furthermore, few published reports describing the 
outbreaks of food-borne and water-borne diseases 
in the country are available [11,12] and information 
on antimicrobial resistance determinants and 
profiles of Salmonella isolates are lacking.  
In view of the emergence of MDR strains and 
their increased involvement in infections and 
outbreaks worldwide, combining antimicrobial 
susceptibility testing and molecular fingerprinting 
of S. Typhi has become an important function in 
public health laboratories (PHLs).  
Molecular tools, such as plasmid analysis and 
Pulsed-Field Gel Electrophoresis (PFGE), 
extensively used in the laboratories of developed 
countries  for characterizing and subtyping 
pathogens, are conversely quite limitedly used in 
laboratories in developing countries, either due to 
the lack of infrastructure or well-trained 
microbiologists. 
For these reasons, collaboration with 
institutions from developed countries represents 
an effective way of improving diagnostic capacity 
of laboratories and facilitates acquisition of well-
established molecular typing methods for 
recognizing and investigating outbreaks of 
communicable disease in developing countries.  
In this context, the WHO Office for Epidemic 
and Pandemic Alert and Response in Lyon has 
launched training programmes for strengthening 
capacity of the national PHLs in developing 
countries such as Jordan, and to facilitate 
collaborative research activities and partnership 
between laboratories from less developed and 
developed countries.  
In the present study we have demonstrated a 
successful example of a joint research activity 
involving the University of Sassari in Italy and the 
Central Laboratory, Ministry of Health, in Jordan, in 
the investigation of a typhoid outbreak that 
occurred between October 2004 and January 2005 
in the Jordan valley and subsequently in the study 
of sporadic cases of typhoid fever that occurred in 
2005. In this report, Salmonella isolates of serovar 
Typhi have been studied for susceptibility to 
antimicrobial agents, molecular determinants of 
resistance, and their localization on plasmid or 
integrons. Furthermore, isolates were investigated 
for their clonal relationship by ribotyping and PFGE 
techniques. 
 
Materials and Methods 
Patients 
From October 2004 to January 2006, 
suspected cases (113 in total) of typhoid fever 
were admitted at six Government Hospitals (Deir 
Alla, Al-shoneeh, Ghor-Alsafi, Alsat, Madaba and 
Al-Karak) located in different directorates in Jordan 
(Table 1). Patients resided in different rural and 
periurban areas mostly from Deir Alla in Jordan 
Valley, about 50 km west of the capital Amman. 
Eighty-three cases of typhoid fever were recovered 
during an outbreak from October 2004 to January 
2005. Thirty more sporadic cases were recorded 
after the outbreak in 2005. All patients exhibited 
fever (≥ 39ºC), abdominal pain and diarrhoea, and 
were treated with ceftriaxone intravenous therapy 
with favourable outcome. 
 
Table 1. Characteristics of Salmonella enterica serovar 
Typhi strains isolated during an outbreak and from 
sporadic cases that occurred in Jordan between 
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 GhorAl-Safi(1) ACCoTS (1) 98 dfrA7 A1 
Sporadic 
isolates Alsalt (8) ACCoTS (8) 98 dfrA7 A1 
 Alkarak (1) ACCoTS (1) 98 dfrA7 A1 
 Deir-Alla (4) ACCoTS (2) 98 dfrA7 A1 





ACCoTS (7) 98 dfrA7 A1 
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 Madaba (4) ACCoTS (4) 98 dfrA7 A1 
A ampicillin, C chloramphenicol, Co cotrimoxazole, T tetracycline, S 
streptomycin; * the variable region of two isolates was sequenced and indicated 
the presence of the dfrA7 gene cassette. 
 
Bacterial isolation  
Forty-eight cases of typhoid fever, 24 epidemic 
(29%) and 24 sporadic (80%) were 
bacteriologically confirmed at the Central 
Laboratory of Ministry of Health in Amman, Jordan. 
Among the epidemic cases, 20 samples were 
positive by blood culture and 5 samples by faecal 
culture (one patient was positive for both faeces 
and blood; only one isolate was used for further 
study). All sporadic samples were blood culture-
positive. Blood samples were cultured in GCC 
mono-phase blood culture bottles at 37°C, 
examined daily up to 7 days, and subcultured 
when turbid on blood, MacConkey and Hektoen 
enteric agar plates (Oxoid, Basingstoke, UK). Stool 
samples were collected in Cary-Blair transport 
medium and subsequently plated onto Selenite 
broth (Oxoid) and cultured on MacConkey and 
Hektoen enteric agar plates. Definitive 
identification of the organism was assessed by use 
of standard biochemical tests followed by 
serotyping with commercial antisera (Biorad, 
Segrate, Italy).  
 
Antimicrobial susceptibility testing 
Sensitivity tests of S. Typhi isolates were 
conducted by the standard disc diffusion method 
and interpreted according to the guidelines 
provided by the National Committee for Clinical 
Laboratory Standards (NCCLS, more recently 
CLSI) [13]. The antibiotic discs (Oxoid) contained 
ampicillin (10 µg), tetracycline (30µg), co-
trimoxazole (25µg), chloramphenicol (30µg), 
streptomycin (10µg), gentamicin (10µg), 
amoxicillin (20µg)-clavulanic acid (10 µg), 
ciprofloxacin (5 µg), nalidixic acid (10µg) and 
cefotaxime (30µg). Escherichia coli ATCC 25922 
was used as a control for the effectiveness of the 
antibiotic discs. 
 
Plasmid profile analysis and PCR for IncHI1 
Plasmid DNA was extracted from S. Typhi 
isolates by the alkaline lysis procedure as 
previously described [14]. Plasmid size was 
determined by comparing to the standard plasmids 
of the V517 and 39R861 E. coli reference strains. 
To determine the plasmid incompatibility group, 
PCR amplification was conducted with specific 




The presence of class 1 and class 2 integrons 
in genome DNA was detected by PCR with 
specific primers for integrase gene intI1 [16]. 
Cassette insertions were detected by sequencing 
the variable region of the class 1 integron amplified 
with 5’CS and 3’CS primers and by PCR with 
specific primers for dhfrA7 [15,16]. 
 
Conjugational transfer of drug resistance 
Conjugational transfers were carried out using 
MDR S. Typhi strains as the donor and E. coli K12 
resistant to kanamycin as the recipient. All mating 
procedures were performed on filters for 18 hours 
at 37°C. Transconjugants were screened on LB 
agar plates containing ampicillin (100 µg/ml), 
kanamycin (50 µg/ml) or tetracycline (10 µg/ml). E. 
coli transconjugants were confirmed by lactose 
fermentation and/or failure to agglutinate Omni-O 
and Vi antisera, and then tested for antibiotic 
susceptibility and analysed for the presence of 
both the plasmid and the intI1 gene.  
 
Ribotyping 
Genomic DNA was extracted according to 
Ausubel et al. [17]. PvuII digested DNA was 
transferred to a nylon membrane (Hybond N+, 
Amersham) using an VacuGeneTM XL vacuum 
system (Pharmacia Biotech) and hybridized with a 
PCR-generated non-radioactive labelled probe for 
16S RNA under stringent conditions as described 
by Stanley et al. [18]. 
 
PFGE genotyping 
A representative set of epidemic and sporadic 
strains of S. Typhi were typed by PFGE according 
to a European standardised protocol described by 
Peters et al. in the Salm-gene project [19]. 
Genomic DNA plugs were digested with 20 units of 
XbaI or SpeI (Promega) and subjected to 
electrophoresis (Pharmacia system) at 14°C for 22 
hours at 180V, interpolating, with a pulse time of 
2s-64s. Analysis of macrorestriction patterns was 
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The outbreak 
The weekly curve of the outbreak (Figure 1) 
shows a constant increase of cases per week until 
17 December 2004, when the incidence of cases 
started to decline. The age group of patients was 
distributed between 2 and 38 years, with a 
predominance in children 5 to 14 years old, as 
shown in Figure 2. 
 
Figure 1. Epidemic curve of the outbreak by week 
number (October 2004-January 2005). 
 
  
Figure 2. Distribution of typhoid cases by age.  
 
 
Bacterial isolates and antimicrobial sensitivity 
testing  
A total of forty-eight S. Typhi strains, 24 from 
the outbreak and 24 sporadic, were isolated from 
bloodstream or stool samples. The table provides 
the details of antibiotic resistance patterns, 
plasmid profiles, integrons, and PFGE patterns 
among the isolates. There was no consistent 
change in antimicrobial resistance patterns. All S. 
Typhi isolates were resistant to streptomycin, 75% 
of which showed additional multidrug resistance to 
ampicillin, chloramphenicol, co-trimoxazole and 
tetracycline (R-type ACCoTS), which represents 
the first-line of drugs for treating typhoid fever in 
Jordan. The MDR strains persisted after the 
outbreak (October 2004-January 2005), whereas 
streptomycin mono-resistant strains seem to 
disappear (Figure 3). None of the isolates 
collected from 2004 to 2006 were resistant to 
nalidixic acid, ciprofloxacin, amoxicillin, gentamicin 
or cefotaxime. 
Figure 3. Trends of Multiple drug resistant (MDR) 
Salmonella enterica serovar Typhi strains from 
epidemic and non-epidemic cases of typhoid fever from 
Jordan (November 2004-January 2006). A, ampicillin; C, 
chloramphenicol; Co, Co-trimoxaxole. 
 
 
Figure 4. Pulsed-field gel electrophoresis (PFGE) 
patterns of S. Typhi isolates from Jordan. A. XbaI patterns 
B. SpeI patterns. M 0.1-200 kb molecular weight marker (Sigma). 
Lanes 1-3, 9: streptomycin resistant isolates; lanes 4-8: MDR isolates. 
 
 
Antibiotic resistance determinants 
We investigated the possible relationship 
between antibiotic resistance and genetic 
determinants (plasmids and integrons). Since 
MDR in S. Typhi is mainly due to large conjugative 
plasmids, strains were subjected to alkali lysis to 
isolate high molecular weight plasmids. A plasmid 
of incompatibility group IncHI1 of about 98 MDa 
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was found in all MDR Typhi isolates (R-type 
ACCoTS); on the contrary, streptomycin resistant 
isolates were plasmid-free (Table 1). R-type 
ACCoTS Typhi also harbored a class 1 integron of 
800bp. Class 2 integrons were not detected. 
Sequencing of class 1 integron variable regions 
revealed the presence of a single gene cassette 
dhfrA7 which confers resistance to trimethoprim. A 
representative number of MDR Typhi isolates were 
tested for the transferability of their resistances to 
E. coli KmR by conjugation experiments. 
Interestingly, resistance to ACCoT, but not 
streptomycin, was co-transferred with the R-
plasmid and the dhfrA7-integron, which was found 
to be plasmid-borne as demonstrated by intI1 gene 
PCR-detection of E. coli tranconjugants. 
 
Molecular fingerprint methods  
In order to study the clonal relationship among 
S. Typhi isolates responsible for the outbreak and 
the relationship between these isolates and those 
from sporadic cases isolated after the outbreak, 
molecular typing was performed by ribotyping and 
PFGE methods on 30 randomly selected strains 
(Table). A remarkable homogeneity of PFGE 
patterns with two to three fragments difference in 
the range 48.5-23.1 kb was identified after analysis 
of DNA restricted with XbaI or SpeI endonucleases 
(Figure 4). Thus, only the results of XbaI digestion 
were used for analysis. In particular, plasmid-free 
isolates lacked the fragments present in MDR 
strains after restriction, relating these fragments to 
plasmid carriage. This association was also 
confirmed by hybridization experiments with a 
specific probe for the integrase 1 gene (data not 
shown). When plasmid-associated bands were 
removed from the analysis, all isolates had an 
identical PFGE pattern. Results also showed 
complete correlation between resistance typing 
and PFGE. The PFGE patterns of S. Typhi isolates 
were compared with the patterns obtained 
previously with an rRNA gene probe. Ribotyping 
identified the clonality by showing a unique pattern 
(data not shown), while the PFGE approach was 
able to discriminate between MDR-plasmid-
bearing and plasmid-free isolates. 
 
Discussion 
Typhoid fever is becoming a serious problem 
in several countries of the Middle East such as 
Oman, Qatar, Kuwait, Saudi Arabia, Turkey and 
Iran [21-25], possibly due to the introduction of 
MDR isolates of S. Typhi by expatriates from the 
Indian sub-continent employed in these countries, 
as well as from nationals visiting the Indian sub-
continent. Although typhoid caused by MDR 
serovar Typhi in most endemic parts of Asia and 
the Indian subcontinent [26,27] have been well 
characterized, to date data on antimicrobial 
resistance among S. Typhi from Jordan are 
limited. 
 This is the first report of S. Typhi from Jordan 
since 1980, which arguably is tightly linked to the 
movement of migrant workers continuously 
employed in the national agricultural field, 
particularly in the Jordan Valley region, the area 
under study in the present investigation. We report 
in this study the characterization of 48 clinical 
isolates of S. Typhi geographically distributed in 
Jordan by combining phenotypic and molecular 
typing methods. The data presented highlight the 
emergence of a high rate of S. Typhi showing 
multiple resistance to the common antimicrobial 
agents used in the treatment of typhoid fever in 
developing countries. The prevalence of MDR 
resistant to ampicillin, chloramphenicol, co-
trimoxazole, streptomycin and tetracycline was 
high in epidemic isolates (58%), but was more 
pronounced (92%) in isolates from sporadic cases 
that occurred in different locations during 2005, 
suggesting a spread of this MDR clone through the 
country. This finding contradicts recent reports 
from some regions where the incidence of MDR 
Typhi isolates appears to have decreased [28,29].  
The high frequency of MDR S. Typhi isolated is 
remarkable, since resistance to first-line drugs will 
require more expensive drugs for effective 
treatment of typhoid fever and may pose a major 
challenge to the health care system. 
However, the susceptibility exhibited to 
fluoroquinolone drugs (nalidixic acid and 
ciprofloxacin) and cefotaxime leaves valuable 
therapeutic options in the treatment of MDR 
typhoid fever. This again contradicts what was 
recently reported from different studies that 
showed an increased incidence of high resistance 
to fluoroquinolone which was also associated with 
treatment failures [30]. 
Interestingly, the emergence of MDR in S. 
Typhi isolates from Jordan is linked to an IncHI1 
[15] conjugative plasmid which mediates multiple 
resistance, demonstrated by conjugation 
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experiments. It has been reported that similar 
plasmids have been isolated in S. Typhi strains 
from different countries in the Middle East and 
Asia that are able to transfer full MDR or partial 
resistance [31], which is similar to our findings. 
The presence of strains harboring the IncHI1 
plasmid after the outbreak is of concern and poses 
the problem of it continuing to spread [32] and 
transfer resistance.  
Besides plasmids, mobile elements contribute 
to the dissemination of antibiotic resistance and 
integrons represent the major vehicle for spread 
[33]. In this study, all MDR S. Typhi strains 
harbored a class 1 integron carrying the dfrA7 
gene cassette, conferring resistance to 
trimethoprim, which is similar to the results of 
earlier studies on other S. Typhi isolates from 
different countries of South East Asia [8,15]. The 
presence of the integron must not be undervalued 
since two reports have already described 
multidrug-resistant S. Typhi strains harboring 
integrons with up to six drug resistance genes 
[34,35]. Furthermore, integrons can acquire 
additional resistance gene cassettes such as veb-
1 or blaVIM, leading to serious problems in the 
management of these infections. 
PFGE of macrorestricted DNA produced two 
major patterns when XbaI and SpeI were used. S. 
Typhi strains circulating in Jordan and responsible 
for the outbreak were most probably derived from 
an introduced clone possessing a plasmid or not, 
based on the analysis of resistance patterns and 
PFGE. Our results indicate that these MDR S. 
Typhi strains are spreading from the outbreak-
affected areas to other regions. This situation is of 
concern and should be carefully monitored in 
Jordan. 
The PFGE pattern of MDR S. Typhi strains 
investigated was apparently identical to one of the 
five XbaI-PFGE-patterns identified as circulating 
MDR S. Typhi strains in Asia and Middle Eastern 
countries in previous studies [8,26,27,36]. These 
findings confirm that MDR strains from Jordan are 
related to those in other countries and could have 
been introduced possibly about November 2004 or 
even before. Unfortunately, no samples  of S. 
Typhi strains are available from previous years to 
investigate that retrospectively.  
Phenotypic and genotypic typing methods 
have been demonstrated to be useful to 
investigate outbreaks and track the spread of MDR 
of S. Typhi in Jordan. Thus, for the implementation 
of national prevention measures, it is important to 
identify the source of an outbreak and to 
understand the mode of transmission of MDR S. 
Typhi. Further studies based on molecular typing 
methods are also needed in Jordan to characterize 
S. Typhi isolates associated with sporadic cases in 
order to compare their genotypic profile to those 
characterized in the current study. Such an effort 
would will provide background information on the 
distribution of MDR S. Typhi strains and enable the 
national health authorities to forecast potential 
sources of outbreak infections.  
In conclusion, this study describes the 
molecular characterization of clinical isolates of S. 
Typhi for the first time in Jordan, and the 
importance of the use of molecular typing 
techniques from a public health perspective. 
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